Erratum to "A single transplantation of the islets can produce glycemic stability and reduction of basal insulin requirement" [Diabetes Res. Clin. Pract. 73 (2006) 235-240] (DOI:10.1016/j.diabres.2006.01.012);A single transplantation of the islets can produce glycemic stability and reduction of basal insulin requirement

Diabetes Research and Clinical Practice

Volumn 73, Issue 3, 2006, Pages 235-240

  Sassa, Mariko ^a   Fukuda, Kazuhito ^a   Fujimoto, Shimpei ^a   Toyoda, Kentaro ^a   Fujita, Yoshihito ^a   Matsumoto, Shinichi ^b   Okitsu, Teru ^a   Iwanaga, Yasuhiro ^a   Noguchi, Hirofumi ^a   Nagata, Hideo ^a   Yonekawa, Yukihide ^a   Ohara, Takeshi ^c   Okamoto, Masahiko ^d   Tanaka, Koichi ^a,b   Seino, Yutaka ^a,e   Inagaki, Nobuya ^a   Yamada, Yuichiro ^a  

^a KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KYOTO UNIVERSITY HOSPITAL   (Japan)

^c KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^e Kansai Denryoku Hospital   (Japan)

Author keywords

A single transplantation of the islets; Living donor; Metabolic stability; Non heart beating donor

Indexed keywords

INSULIN;

ADULT; AMPLITUDE MODULATION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; MALE; PANCREAS ISLET TRANSPLANTATION;

EID: 33746294818     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2006.08.007     Document Type: Erratum

References (26)

1. Schlichtkrull J., Munck O., and Jersild M. The M-value, an index of blood-sugar control in diabetics. Acta Med. Scand. 177 (1965) 95-102
2. Service F.J., Molnar G.D., Rosevear J.W., Ackerman E., Gatewood L.C., Taylor W.F., et al. Mean amplitude of glycemic excursions, a measure of diabetic instability. Diabetes 19 (1970) 644-655
3. Service F.J., and Nelson R.L. Characteristics of glycemic stability. Diabetes Care 3 1 (1980) 58-62
4. The Diabetes Control and Complications Trial (DCCT) Research Group. Early worsening of diabetic retinopathy in the Diabetes Control and Complications Trial. Arch. Ophthalmol. 116 (1998) 874-876
5. Allen K.V., and Frier B.M. Nocturnal hypoglycemia: clinical manifestations and therapeutic strategies toward prevention. Endocr. Pract. 9 6 (2003) 530-543
6. Shapiro A.M.J., Lakey J.R.T., Ryan E.A., Korbutt G.S., Toth E., Warnock G.L., et al. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N. Engl. J. Med. 343 (2000) 230-238
7. Ryan E.A., Lakey J.R.T., Paty B.W., Imes S., Korbutt G.S., Kneteman N.M., et al. Successful islet transplantation Continued insulin reserve provides long-term glycemic control. Diabetes 51 (2002) 2148-2157
8. Hering B.J., Kandaswamy R., Ansite J.D., Eckman P.M., Nakano M., Sawada T., et al. Single-donor, marginal-dose islet transplantation in patients with type 1 diabetes. JAMA 293 (2005) 830-835
9. Matsumoto S., Okitsu T., Iwanaga Y., Noguchi H., Nagata H., Yonekawa Y., et al. Insulin independence after living-donor pancreatectomy and islet allotransplantation. Lancet 365 9741 (2005) 1642-1644
10. S. Matsumoto, T. Okitsu, Y. Iwanaga, H. Noguchi, H. Nagata, Y. Yonekawa, et al., Successful islet transplantation from non-heart-beating donor pancreata using modified Ricordi islet isolation method, Transplantation, in press.
11. 1c. Diabetes Care 25 (2002) 275-278
12. 1c Value of JDS Lot 2 Determined by NSGP. J. Jpn. Diab. Soc. 45 5 (2002) 385-388
13. Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N. Engl. J. Med. 329 (1993) 977-986
14. Ohkubo Y., Kishikawa H., Araki E., Miyata T., Isami S., Motoyoshi S., et al. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study. Diab. Res. Clin. Pract. 28 (1995) 103-117
15. Shapiro A.M.J., Lakey J.R.T., Paty B.W., Senior P.A., Bigam D.L., and Ryan E.A. Strategic opportunities in clinical islet transplantation. Transplantation 79 (2005) 1304-1307
16. Epidemiology of Diabetes Interventions and Complications (EDIC) Research Group. Epidemiology of Diabetes Interventions and Complications (EDIC). Diabetes Care 22 (1999) 99-111
17. The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy. N. Engl. J. Med. 342 (2000) 381-389
18. The Writing Team for the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus. JAMA 287 (2002) 2563-2569
19. The Writing Team for the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. Sustained effect of intensive treatment of type 1 diabetes mellitus on development and progression of diabetic nephropathy. JAMA 290 (2003) 2159-2167
20. The Diabetes Control and Complications Trial/ Epidemiology of Diabetes Interventions and Complications Research Group. Intensive diabetes therapy and carotid intima-media thickness in type 1 diabetes mellitus. N. Engl. J. Med. 348 (2003) 2294-2303
21. Riddle M.C., Rosenstock J., and Gerich J. The Treat-to-Target Trial: randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients. Diabetes Care 26 (2003) 3080-3086
22. Rosenstock J. Basal insulin supplementation in type 2 diabetes: refining the tactics. Am. J. Med. 116 3A (2004) 10S-16S
23. Rosenstock J., Dailey G., Massi-Benedetti M., Fritsche A., Lin Z., and Salzman A. Reduced hypoglycemia risk with insulin glargine: a meta-analysis comparing insulin glargine with human NPH insulin in type 2 diabetes. Diabetes Care 28 (2005) 950-955
24. Radu R.G., Fujimoto S., Mukai E., Takehiro M., Shimono D., Nabe K., et al. Tacrolimus suppresses glucose-induced insulin release from pancreatic islets by reducing glucokinase activity. Am. J. Physiol. 288 (2005) E365-E371
25. Bell E., Cao X., Moibi J.A., Greene S.R., Young R., Trucco M., et al. Rapamycin has a deleterious effect on MIN-6 cells and rat and human islets. Diabetes 52 (2003) 2731-2739
26. Paty B.W., Harmon J.S., Marsh C.L., and Robertson R.P. Inhibitory effects of immunosuppressive drugs on insulin secretion from HIT-T15 cells and Wister rat islets. Transplantation 73 3 (2002) 353-357